BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Tonix Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights

  Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2022, and provided an overview of recent operational highlights.

  May 9, 2022

   · 

  18 min read
• Drug Development

  Athira Pharma Extends Ongoing Open Label Extension Study for LIFT-AD and ACT-AD Clinical Trials of Fosgonimeton (ATH-1017) for Mild to Moderate Alzheimer’s Disease

  Athira Pharma, Inc. today announced that it is extending the length of the current open label extension (OLEX) study for its Phase 3 LIFT-AD and Phase 2 ACT-AD studies of fosgonimeton.

  May 9, 2022

   · 

  7 min read
• Drug Development

  Mereo BioPharma announces Positive Top-Line Efficacy and Safety Data from “ASTRAEUS” Phase 2 Trial of Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Emphysema

  Mereo BioPharma Group plc today announced positive top-line efficacy and safety results from “ASTRAEUS” a Phase 2 study of the investigational oral neutrophil elastase (NE) inhibitor, alvelestat (MPH-966).

  May 9, 2022

   · 

  14 min read
• Deals

  Axsome Therapeutics Completes U.S. Acquisition of Sunosi® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea

  Axsome Therapeutics, Inc., a biopharmaceutical company developing novel therapies for the management of central nervous system disorders, announced the completion of its U.S. acquisition of Sunosi® from Jazz Pharmaceuticals.

  May 9, 2022

   · 

  14 min read
• Genetown

  Ginkgo Bioworks Announces Date of First Quarter 2022 Results Presentation

  Ginkgo Bioworks announced today that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2022, on Monday, May 16.

  May 9, 2022

   · 

  1 min read
• Business

  BaroPace Adds Michael Coyle to Board

  BaroPace, Inc. announces the appointment of Michael Coyle to BaroPace’s Board of Directors.

  May 9, 2022

   · 

  2 min read
• Business

  LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update

  LENSAR, Inc. today announced financial results for the quarter ended March 31, 2022 and provided an update on operational initiatives.

  May 9, 2022

   · 

  11 min read
• BioMidwest

  Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Conference

  Exicure, Inc. today announced a poster presentation at TIDES USA 2022, May 9-12, 2022.

  May 9, 2022

   · 

  1 min read
• Business

  ADC Therapeutics Announces CEO Transition

  ADC Therapeutics SA announced that Chris Martin, DPhil, has stepped down as Chief Executive Officer.

  May 9, 2022

   · 

  6 min read
• Business

  Adaptimmune Reports First Quarter 2022 Financial Results and Business Update

  Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, reported financial results for the first quarter ended March 31, 2022 and provided a business update.

  May 9, 2022

   · 

  10 min read